ArticleCancers2021

Targeting HSF1 as a Therapeutic Strategy for Multiple Mechanisms of EGFR Inhibitor Resistance in EGFR Mutant Non-Small-Cell Lung Cancer.

Sangah Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.